Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Sells SNP Genotyping Business to Beckman Coulter

NEW YORK, Dec. 23 - Orchid BioSciences said last week that Beckman Coulter acquired its SNP genotyping instrumentation business.


Beckman Coulter acquired the rights to Orchid's SNP genotyping instrumentation, reagents, and software formerly marketed by Orchid Life Sciences, according to the companies. Beckman Coulter also received an exclusive license to use Orchid's SNP-IT SNP analysis technology in products sold to research and specialty-testing markets, and a non-exclusive license to use SNP-IT in the field of diagnostics.


Orchid retained rights to use SNP-IT technology in the diagnostics market and in its genoprofiling service businesses. The company also said it will continue to use SNP-IT technology for its pharmaceutical and agricultural customers. Orchid has retained the rights to its portfolio of SNP technology patents.


Beckman Coulter paid Orchid via cash and the assumption of debt obligations. Financial details of the agreement were not disclosed.


Orchid announced in November its intention to sell off a portion of its life sciences business.


"The sale of assets of our Orchid life sciences business to Beckman Coulter marks another milestone in our ongoing progress to sharpen our business focus," Andrew Savadelis, chief financial officer of Orchid, said in a statement. Savadelis predicted that the sale would help Orchid become profitable towards the end of 2003.


Click here for more information.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.